These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 28441138)

  • 1. Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy.
    Masemann D; Boergeling Y; Ludwig S
    Biol Chem; 2017 Jul; 398(8):891-909. PubMed ID: 28441138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
    Park GT; Choi KC
    Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
    Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
    Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of virotherapy for effective tumor treatment.
    Garcia-Aragoncillo E; Hernandez-Alcoceba R
    Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in cancer virotherapy: bringing the immune system into play.
    Boisgerault N; Tangy F; Gregoire M
    Immunotherapy; 2010 Mar; 2(2):185-99. PubMed ID: 20635927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Going viral: a review of replication-selective oncolytic adenoviruses.
    Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
    Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.
    Kim J; Hall RR; Lesniak MS; Ahmed AU
    Viruses; 2015 Nov; 7(12):6200-17. PubMed ID: 26633462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic virotherapy.
    Cervantes-García D; Ortiz-López R; Mayek-Pérez N; Rojas-Martínez A
    Ann Hepatol; 2008; 7(1):34-45. PubMed ID: 18376364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic viruses in the treatment of cancer: a review of current strategies.
    Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
    Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virotherapy: Challenges and solutions.
    Goradel NH; Baker AT; Arashkia A; Ebrahimi N; Ghorghanlu S; Negahdari B
    Curr Probl Cancer; 2021 Feb; 45(1):100639. PubMed ID: 32828575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic viral therapies - the clinical experience.
    Aghi M; Martuza RL
    Oncogene; 2005 Nov; 24(52):7802-16. PubMed ID: 16299539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer.
    Rao MFS; Ahmed B; Qadir MI
    Crit Rev Eukaryot Gene Expr; 2024; 34(1):1-13. PubMed ID: 37824388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy.
    Lal G; Rajala MS
    Cancer Gene Ther; 2018 Oct; 25(9-10):216-226. PubMed ID: 29735993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.